![Michael Bolinder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Michael Bolinder worked at Mallinckrodt Pharmaceuticals Ltd. from 2013 to 2015 as Head-Marketing & Commercial Strategy.
From 2015 to 2022, Mr. Bolinder was at Acacia Pharma Group Ltd., serving as Chief Executive Officer from 2019 to 2022.
Mr. Bolinder completed undergraduate education at Florida State University.
Antiguos cargos conocidos de Michael Bolinder.
| Empresas | Cargo | Fin |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Director Ejecutivo | 01/06/2022 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Ventas & Marketing | 01/08/2015 |
Formación de Michael Bolinder.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
7
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- Michael Bolinder
Elige MarketScreener 
